ServiziMenu principaleHome
You are here: Home > About us > ESO core faculty > Cancer Research

Cancer Research

Adriana Albini, IRCCS MultiMedica, Vascolar Biology and Angiogenesis Dpt., Milan, Italy
Sanaa Al Sukhun, Amman, Jordan
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Melina Arnold, International Agency for Research on Cancer (WHO/IARC), Section of Cancer SurveillancE, Lyon, France
Hatem A. Azim Jr., American University Beirut, Internal Medicine Dpt.,Beirut, Lebanon
Rajendra Badwe, Tata Memorial Hospital    Dept. of Surgical Oncology, Mumbai, India
Joaquim Bellmunt, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, Boston, MA, USA
Jonas Bergh, Karolinska Institute & University Hospital    Department of Oncology-Pathology, Stockholm, Sweden
Jacques Bernier, Swiss Medical Network, Dept. of Radio-Oncology, Genolier, Switzerland
Paolo Bruzzi, National Institute for the Research on Cancer, Clinical Epidemiology Dpt., Genoa, Italy
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Franco Cavalli, San Giovanni Hospital, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Thomas Cerny, Kantonsspital, Dept. of Oncology/Hematology, St. Gallen, Switzerland
Fortunato Ciardiello, Second University of Naples, Medical surgical Dpt., Naples, Italy
Frank Claessens, University of Leuven, Dept. of Cellular and Molecular Medicine, Leuven, Belgium
Mike Clarke, Queen's University Belfast, Centre for Public Health, Belfast, United Kingdom
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, Ireland
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Romano Danesi, University of Pisa, Sperimental and Clinical Medicine Dpt., Pisa, Italy
Filippo De Braud, IRCCS Foundation – National Cancer Institute, Medical Oncology Dpt., University of Milan, Milan, Italy
Andrea De Censi, E.O. Galliera Hospitals, S.C. Preventive and Medical Oncology Dpt., Genoa, Italy
Francesco De Lorenzo, ECPC, Roma, Italy
Maurizio D'Incalci, IRSCC – Pharmacological Researches Mario Negri, Dept. Of Oncology, Milan, Italy
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School, Oncology Dpt., Boston, USA
Gian Paolo Dotto, University of Lausanne, Dept. of Biochemistry, Epalinges, Switzerland
Rosalind Eeles, The Institute of Cancer Research, Dept. of Oncogenetics, Sutton, Surrey, United Kingdom
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Aleksandra Filipovic, London, United Kingdom
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
William D. Foulkes, McGill University, Dept. of Human Genetics, Montreal, Canada
Silvia Franceschi, International Agency for Research on Cancer (WHO/IARC), Infections and Cancer Epidemiology Group, Lyon, France
Milo Frattini, Pathology Cantonal Institute, Molecular Patology Lab., Locarno, Switzerland
Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Sara Gandini, European Institute of Oncology, Dept. of Epidemiology and Biostatistics, Milan, Italy
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Salvatore Grisanti, ASST Spedali Civili, Medical Oncology Dpt., Brescia, Italy
John Ioannidis, Stanford Prevention Research Center, Stanford, USA
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Guido Jenster, Erasmus University Medical Center, Urology Dpt., Rotterdam, The Netherlands
V. Craig Jordan, University of Texas M.D. Anderson Cancer Center, Breast Medical Oncology Dpt / Molecular and Cellular Oncology Dpt., Houston, USA
Stein Kaasa, Oslo University Hospital, Medival Faculty, Oslo, Norway
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Denis Lacombe, EORTC Data Center, NDDP, Brussels, Belgium
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Rolf Marti, Swiss Cancer League    Scientific Office, Bern, Switzerland
Jose M. Martin Moreno, Universitat de Valencia, Preventive Medicine and Public Health, Valencia, Spain
Olivier Michielin, Lausanne University Hospital - CHUV    Dept. of Medical Oncology, Lausanne, Switzerland
Peter Naredi, Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, Sweden
Pier Giuseppe Pelicci, European Institute of Oncology, Dept. of Experimental Oncology, Milan, Italy
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management Department Oncology, Haematology & Diagnostics, London, United Kingdom
Herbert Michael Pinedo, Willemstad, Curacao, Netherlands, Antilles
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada
Giancarlo Pruneri, University of Milan – IRCCS Foundation – National Cancer Institute, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milan, Italy
Christian Rolfo,University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Roman Rouzier, Insitut Curie, Service de Chirurgie, Paris, France
Helene Rundqvist, Karolinska Institutet, Dept. of Cell and Molecular Biology, Stockholm, Sweden
Mahasti Saghatchian d'Assignies, Institut Gustave Roussy, Dept. of Medical Oncology, Villejuif, France
Ramon Salazar, Institut Català d'Oncologia, Servicio de Oncologia Medica, Barcelona, Spain
Andrea Sartore-Bianchi, Grande Ospedale Metropolitano Niguarda, Haematology and Oncology Dpt. - Niguarda Cancer Center, Milan, Italy
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Fritz Schröder, Erasmus University, Dept. of Urology, Rotterdam, The Netherlands
Michael Seckl, Imperial College London, Hammersmith Campus, London, United Kingdom
Jalid Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany
Piergiorgio Solli, Hospital Unit of Forlì, U.O. Thoracic surgery dpt., Forlì, Italy
Christos Sotiriou, Institut Jules Bordet, Free University of Bruxelles, Breast Cancer Translational Research Laboratory J.C. Heuson, Brussels, Belgium
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Richard Sullivan, Kings Health Partners, King's College, Integrated Cancer Centre, London, United Kingdom
Riccardo Valdagni, IRCCS Foundation – National Cancer Institute, Prostate Cancer Programme and Division of Radiation Oncology 1, Milan, Italy
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands
Yvonne Wengström, Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div of Nursing, Huddinge, Sweden
Paul Workman, The Institute of Cancer Research, London, United Kingdom
Yosef Yarden, The Weizmann Institute of Science, Dept. of Biological Regulation, Rehovot, Israel

Follow us